Episodes of Hypoglycemia in Patients with Parkinson’s Disease – Results of Two-Week Continuous Glucose Monitoring
Objective: The study aimed to determine the incidence of hypoglycemic episodes in patients with Parkinson's disease (PD) and assess risk factors for these episodes. Background:…Orthostatic Hypotension：a Clinical Marker for the Body-First Subtype of Patients with Parkinson’s Disease
Objective: Our study aimed to investigate the clinical characteristics of PD patients stratified by OH status before and after levodopa challenge to explore the hypothesis…Clinical and Neuroimaging Biomarker Predictors of Autonomic Dysfunction in Parkinson’s Disease: A Study Using PPMI Data
Objective: To evaluate whether clinical and neuroimaging baseline markers predict the onset of significant dysautonomia over five years in individuals with idiopathic, de novo Parkinson's…Nocturnal Bradykinesia is better detected using wearable sensors in Parkinson’s disease compared to clinical outcome
Objective: To evaluate the range and motor state during sleep of PD patients by using subjective scale-based assessment as well as PKG. To evaluate the…Patients with Parkinson’s disease have frequently pincer nail deformity
Objective: The purpose of this study is to investigate whether the patients with Parkinson's disease have frequently pincer nail deformity (PND). Background: In our routine…Gender-related Cognitive Disparities in Hispanic Patients with Parkinson’s Disease: A Cross-Sectional Study
Objective: Investigate potential gender-based cognitive performance disparities within the Hispanic population diagnosed with Parkinson's disease (PD). Background: PD significantly impairs cognitive functions, adversely affecting the…Two unusual cases of dopamine dysregulation syndrome in patients with Parkinson’s disease
Objective: To present two cases of dopamine dysregulation syndrome (DDS) in patients with Parkinson’s disease (PD) who took extreme measures to access more dopaminergic medication.…GPR30 agonists attenuate haloperidol-induced neurotoxicity in SH-SY5Y cells and adult zebrafish.
Objective: Objective:1. To investigate the neuroprotective effect of FDA-approved compounds (Raloxifene and Fulvestrant) against haloperidol-induced neurotoxicity in SHSY-5Y cells and adult zebrafish2. To explore the molecular…Oro-facial Dyskinesia and akathisia following Treatment by Olanzapine
Objective: To report the case of a pharmaco-induced oro-facial dyskinesia and akathisia. Background: Dyskinesia is a hyperkinetic, disorganized, involuntary movement disorder that can either be…Parkinson’s Disease Burden in Underserved Populations Across the US in 2022
Objective: To examine disparities in Parkinson’s disease (PD) burden by race or ethnicity, age, sex and region in the US. Background: PD is the second…
- « Previous Page
- 1
- …
- 77
- 78
- 79
- 80
- 81
- …
- 181
- Next Page »